Literature DB >> 8840069

Potassium channel agonists modify the local anaesthetic activity of bupivacaine in mice.

M Gantenbein1, L Attolini, B Bruguerolle.   

Abstract

PURPOSE: The mechanisms of action of local anaesthetics and potassium channel agonists (PCAs) may interfere by acting in a direct or indirect manner on the same ion channels. In a previously reported study, the bupivacaine-induced mortality was shown to be modified in different ways by four PCAs tested (diazoxide (D), levcromakalim (L), nicorandil (N) and pinacidil (P)) since bupivacaine-induced mortality was increased by high doses of P and L, decreased by N and stayed unchanged by D. The present study was designed to document the changes in bupivacaine (B) local anaesthetic activity in mice after a single injection of one of the four PCAs (D, L, N and P).
METHODS: Each PCA was tested at three different dosages. Controls received saline. The local anaesthetic activity was evaluated using sciatic nerve blockade. After injection of bupivacaine in the region of the sciatic nerve, the local anaesthetic activity was estimated as the loss of motor control of the injected limb.
RESULTS: PCA treatment increased (P = 0.0001) the time needed for recovery from bupivacaine-induced local anaesthesia. The area under the effect vs time curve, assessing the total anaesthetic effect, was greater for N (P = 0.0016) and P (P = 0.038) but not for L (P = 0.11). Compared with controls, the maximal effect (Emax) was less for D (P = 0.009) and N (P = 0.038) but not for L (P = 0.185) or P (P = 0.45) treated groups. The injection of the PCA in the region of the sciatic nerve of the right hindlimb did not induce any alteration of the motor activity of the injected limb.
CONCLUSION: The four PCAs decreased the maximal local anaesthetic effect and increased the duration of action of bupivacaine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8840069     DOI: 10.1007/BF03013042

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  15 in total

Review 1.  Potassium channel openers: pharmacological and clinical aspects.

Authors:  U Quast
Journal:  Fundam Clin Pharmacol       Date:  1992       Impact factor: 2.748

Review 2.  Structure-activity relationships of K+ channel openers.

Authors:  G Edwards; A H Weston
Journal:  Trends Pharmacol Sci       Date:  1990-10       Impact factor: 14.819

Review 3.  Potassium channel openers. Pharmacological effects and future uses.

Authors:  S Duty; A H Weston
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

Review 4.  Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscle.

Authors:  T C Hamilton; A H Weston
Journal:  Gen Pharmacol       Date:  1989

5.  A sciatic nerve blockade method to differentiate drug-induced local anesthesia from neuromuscular blockade in mice.

Authors:  K Leszczynska; S T Kau
Journal:  J Pharmacol Toxicol Methods       Date:  1992-04       Impact factor: 1.950

Review 6.  Do the K+ channel openers relax smooth muscle by opening K+ channels?

Authors:  U Quast
Journal:  Trends Pharmacol Sci       Date:  1993-09       Impact factor: 14.819

7.  Effect of four potassium channel agonists on bupivacaine-induced toxicity in mice.

Authors:  M Gantenbein; L Attolini; B Bruguerolle
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

8.  Local anesthetics block transient outward potassium currents in rat neocortical neurons.

Authors:  M Andreasen; J J Hablitz
Journal:  J Neurophysiol       Date:  1993-06       Impact factor: 2.714

9.  Comparison of effects of selected local anesthetics on sodium and potassium channels in mammalian neuron.

Authors:  S Stolc
Journal:  Gen Physiol Biophys       Date:  1988-04       Impact factor: 1.512

10.  Potassium channel blockers potentiate impulse inhibition by local anesthetics.

Authors:  D Drachman; G Strichartz
Journal:  Anesthesiology       Date:  1991-12       Impact factor: 7.892

View more
  2 in total

Review 1.  [Toxicology of local anesthetics. Clinical, therapeutic and pathological mechanisms].

Authors:  W Zink; B M Graf
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

2.  Poly(lactide-co-glycolide) nanocapsules containing benzocaine: influence of the composition of the oily nucleus on physico-chemical properties and anesthetic activity.

Authors:  Nathalie Ferreira Silva de Melo; Renato Grillo; Viviane Aparecida Guilherme; Daniele Ribeiro de Araujo; Eneida de Paula; André Henrique Rosa; Leonardo Fernandes Fraceto
Journal:  Pharm Res       Date:  2011-04-07       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.